TH19232A - How to stop uterine-like tissue occurring in different locations - Google Patents
How to stop uterine-like tissue occurring in different locationsInfo
- Publication number
- TH19232A TH19232A TH9401002212A TH9401002212A TH19232A TH 19232 A TH19232 A TH 19232A TH 9401002212 A TH9401002212 A TH 9401002212A TH 9401002212 A TH9401002212 A TH 9401002212A TH 19232 A TH19232 A TH 19232A
- Authority
- TH
- Thailand
- Prior art keywords
- chemical formula
- different locations
- tissue occurring
- uterine
- salt
- Prior art date
Links
- 239000000126 substance Substances 0.000 claims abstract 9
- 150000001875 compounds Chemical class 0.000 claims abstract 4
- 150000003839 salts Chemical class 0.000 claims abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 2
- 239000001257 hydrogen Substances 0.000 claims abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Abstract
วิธียับยั้งภาวะเนื้อเยื่อคล้ายมดลูกเกิดในที่ต่าง ๆ ประกอบด้วยการ ให้สารประกอบซึ่งมีสูตรต่อไปนี้ในปริมาณที่ทำให้เกิดผลแก่คนที่ต้องการรักษา (สูตรเคมี) ซึ่ง R1 และ R3 เป็นอิสระต่อกันคือไฮโดรเจน, (สูตรเคมี) หรือ (สูตรเคมี) ซึ่ง Ar คือเฟนิลซึ่งเลือกถูกแทนที่; R2เลือกจากกลุ่มที่ประกอบด้วยพิโรลิดิโนและฟอดพอริดิโน, เกลือหรือ โซลเวทของสารเหล่านั้นซึ่งเป็นที่ยอมรับทางเภสัชศาสตร์ สิทธิบัตรยา Methods for inhibiting uterine-like tissue occurring in different places include: Gives a compound with the following formula in an effective quantity to the person who wants to maintain (chemical formula) where R1 and R3 are independent of hydrogen, (chemical formula) or (chemical formula) where Ar is phenyl which is chosen to be replaced; R2 chooses from a group containing pirolidino and fodporidino, salt or solvate of those substances, which are recognized in the pharmacy, drug patent.
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH19232A true TH19232A (en) | 1996-06-21 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950010893A (en) | How to suppress endometriosis | |
| KR950016732A (en) | How to suppress skin and vaginal atrophy | |
| KR950016731A (en) | How to suppress seborrhea and acne | |
| ATE153022T1 (en) | 3',5'-DITERTBUTYL-4'-HYDROXYFLAVONES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION HAVING ANTIOXIDATION AND ANTIVASOCONSTRICTION ACTIVITY | |
| DE69430465D1 (en) | Inhibition of uterine fibrosis | |
| KR950010887A (en) | How to inhibit cartilage degeneration | |
| GEP20053626B (en) | Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof | |
| RU98113525A (en) | The use of 2-phenyl-3-aroylbenzothiophenes for the inhibition of thrombotic disorder, to increase the activation of protein C | |
| KR960006915A (en) | Therapeutic composition of pancreatitis | |
| KR950010891A (en) | How to treat resistant tumors | |
| TH19232A (en) | How to stop uterine-like tissue occurring in different locations | |
| NO980531L (en) | Medication to inhibit addiction and tolerance developed by narcotic painkillers | |
| HUP9802348A2 (en) | Use of 2-phenyl-3-aroyl-benzotiophenes for producing medicaments having plasminogen activator inhibitor-1 activity | |
| KR950016720A (en) | How to inhibit the effects of amyloid protein | |
| NZ296285A (en) | Inhibiting physiological conditions associated with bradykinin using a benzothiophene such as raloxifene | |
| KR950016736A (en) | How to suppress male infertility | |
| TH18311A (en) | How to treat the symptoms around Amenorrhea | |
| TH25615A (en) | How to inhibit myiloperoxidase agility | |
| KR950016739A (en) | How to suppress obsessive and wasting diseases | |
| TH17050A (en) | How to inhibit the repair of imperfect tissue | |
| ATE357233T1 (en) | ACTIVE INGREDIENTS COMBINATION CONTAINING A COMPOUND WITH OPIOID EFFECTIVENESS AND A FURTHER COMPOUND OF FORMULA I | |
| TH21233A (en) | How to stop uterine cancer | |
| TH21375A (en) | How to reduce scars when the wound is healed | |
| TH18310A (en) | Drug-resistant Tumor Treatment | |
| TH19372A (en) | A process for retrieving the remainder of the input attached to the sorbent. |